Xylo Technologies Ltd
XYLO
$5.00
$0.091.83%
Weiss Ratings | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.36 | |||
Price History | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.76% | |||
30-Day Total Return | 3.95% | |||
60-Day Total Return | 24.69% | |||
90-Day Total Return | 69.11% | |||
Year to Date Total Return | 35.50% | |||
1-Year Total Return | -31.82% | |||
2-Year Total Return | -54.38% | |||
3-Year Total Return | -86.77% | |||
5-Year Total Return | -86.71% | |||
52-Week High % Change | -43.35% | |||
52-Week Low % Change | 85.19% | |||
Price | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $8.83 | |||
52-Week Low Price | $2.70 | |||
52-Week Low Price (Date) | Aug 08, 2024 | |||
52-Week High Price (Date) | May 21, 2024 | |||
Valuation | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.66M | |||
Enterprise Value | 1.37M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -934.67 | |||
Earnings Per Share Growth | -0.53% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.00 | |||
Price/Book (Q) | 0.01 | |||
Enterprise Value/Revenue (TTM) | 0.02 | |||
Price | $5.00 | |||
Enterprise Value/EBITDA (TTM) | -0.26 | |||
Enterprise Value/EBIT | -0.13 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 18.00K | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $2.13 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $2.13 | |||
Company Info | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | -- | |||
Website | www.medigus.com | |||
Country | Israel | |||
Year Founded | 1999 | |||
Profitability | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -18.64% | |||
Profit Margin | -27.74% | |||
Management Effectiveness | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -10.75% | |||
Return on Equity | -- | |||
Income Statement | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 57.64M | |||
Total Revenue (TTM) | 57.64M | |||
Revenue Per Share | $3,202.33 | |||
Gross Profit (TTM) | 7.80M | |||
EBITDA (TTM) | -5.21M | |||
EBIT (TTM) | -10.75M | |||
Net Income (TTM) | -15.99M | |||
Net Income Avl. to Common (TTM) | -15.99M | |||
Total Revenue Growth (Q YOY) | -63.84% | |||
Earnings Growth (Q YOY) | -24.63% | |||
EPS Diluted (TTM) | -934.67 | |||
EPS Diluted Growth (Q YOY) | 15.40% | |||
Balance Sheet | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 9.51M | |||
Cash Per Share (Q) | $528.17 | |||
Total Current Assets (Q) | 19.44M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 15.92M | |||
Current Ratio (Q) | 0.950 | |||
Book Value Per Share (Q) | $842.60 | |||
Total Assets (Q) | 39.29M | |||
Total Current Liabilities (Q) | 20.47M | |||
Total Debt (Q) | 6.49M | |||
Total Liabilities (Q) | 23.37M | |||
Total Common Equity (Q) | 15.19M | |||
Cash Flow | XYLO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 2.73M | |||
Cash from Financing (TTM) | -4.27M | |||
Net Change in Cash (TTM) | -5.68M | |||
Levered Free Cash Flow (TTM) | 8.38M | |||
Cash from Operations (TTM) | -4.11M | |||